Utama › Leukemia Mielomonositik Juvenil › Texas
Kajian klinikal Leukemia Mielomonositik Juvenil di Texas
3 kajian untuk Leukemia Mielomonositik Juvenil sedang mencari peserta di lokasi di Texas.
Teks kajian rasmi (Bahasa Inggeris)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Children's Medical Center, Dallas
Mengambil pesertaFasa 1/2
1 Month – 21 Years · Semua jantina · Dikemas kini 4 Sep 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Mengambil pesertaFasa 1
Umur 1 hingga 18 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- dan 10 lagi
Mengambil pesertaFasa 1/2
Sehingga umur 22 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04726241Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.